Comparison of Transversalis Fascia Plane Block and Erector Spinae Plane Blocks in Cesarean Section
1 other identifier
interventional
60
1 country
2
Brief Summary
Cesarean section is one of the most common major surgical procedures performed worldwide,, Post-cesarean analgesia should provide adequate pain control while allowing the mother to remain active to meet the needs of the baby. Insufficient analgesia after cesarean section may be associated with acute postoperative pain, chronic pain, higher opioid consumption, delayed functional capacity, and postpartum depression. Techniques such as neuraxial techniques, oral and intravenous agents, wound infiltration, and behavioral therapy can be used in the treatment of post-cesarean pain pain. In addition, Transversus abdominis plane block (TAP), Quadratus Lumborum block (QLB), Erector Spina block (ESP), Transversalis Fascia plane block (TFP) are used safely under ultrasound guidance. In this study, it was aimed primarily to examine the effects of TFP and ESP blocks on pain scores, and secondarily to evaluate analgesic consumption.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable pain
Started Dec 2025
Shorter than P25 for not_applicable pain
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 4, 2021
CompletedFirst Posted
Study publicly available on registry
November 11, 2021
CompletedStudy Start
First participant enrolled
December 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
December 22, 2025
December 1, 2025
6 months
November 4, 2021
December 16, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Opioid Consumption
Opioid consumption postroperative period
Postoperative first 24 hours
Secondary Outcomes (1)
Visual Analog Pain Score
Postoperative first 24 hours
Study Arms (2)
Group ESP
ACTIVE COMPARATORUltrasound-guided erector spinae plane block with 20 ml %0.25 bupivacaine, per side
Group TFP
ACTIVE COMPARATORUltrasound-guided Transversalis Fascia Plane Block block with 20 ml %0.25 bupivacaine, per side
Interventions
Ultrasound-guided block with 20 ml %0.25 bupivacaine, per side
Eligibility Criteria
You may qualify if:
- Between 18-50 years
- Cesarean Section
You may not qualify if:
- Cesarean Section under general anesthesia
- emergency cases
- those with a body mass index greater than 35 kg/m2
- coagulopathy
- local infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Erzurum Regional Training and Research Hospital
Erzurum, Yakutiye, 25100, Turkey (Türkiye)
Erzurum Regional Training and Research Hospital
Erzurum, Yakutiye, 25100, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor
Study Record Dates
First Submitted
November 4, 2021
First Posted
November 11, 2021
Study Start
December 20, 2025
Primary Completion (Estimated)
June 15, 2026
Study Completion (Estimated)
June 30, 2026
Last Updated
December 22, 2025
Record last verified: 2025-12